Phase III trial of NLX P101 in patients with Parkinson's disease.
Phase of Trial: Phase III
Latest Information Update: 16 Mar 2011
At a glance
- Drugs NLX P101 (Primary)
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Sponsors Neurologix
- 16 Mar 2011 Trial is still being planned.
- 07 May 2008 New trial record.